The DOI matches its Crossref record; 185 of the 185 references it cites were found in a registry or an index.
Neuroprotection in Glaucoma: Animal Models and Clinical Trials
Open accessAbstract
Glaucoma is a progressive neurodegenerative disease that frequently results in irreversible blindness. Glaucoma causes death of retinal ganglion cells (RGCs) and their axons in the optic nerve, resulting in visual field deficits and eventual loss of visual acuity. Glaucoma is a complex optic neuropathy, and a successful strategy for its treatment requires not only better management of known risk factors such as elevated intraocular pressure and the development of improved tools for detecting RGC injury but also treatments that address this injury (i.e., neuroprotection). Experimental models of glaucoma provide insight into the cellular and molecular mechanisms of glaucomatous optic neuropathy and aid the development of neuroprotective therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“To our knowledge, this is the first example of vision loss reversal after glaucomatous injury has occurred, with previous attempts focusing on neuroprotection delivered at an early stage to prevent further disease progression41,42 (Supplementary discussion).”
From Reprogramming to recover youthful epigenetic information and restore vision (2020) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000412 · Cited by 7,300
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier
Makadia, H. K., & Siegel, S. J. (2011) · Polymers · doi:10.3390/polym3031377 · Cited by 4,816
The Ocular Hypertension Treatment Study
Kass, M. A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.6.701 · Cited by 3,736
Phototransduction by retinal ganglion cells that set the circadian clock
Berson, D. M., Dunn, F. A., & Takao, M. (2002) · Science · doi:10.1126/science.1067262 · Cited by 3,629
Reduction of Intraocular Pressure and Glaucoma Progression
Heijl, A. (2002) · Archives of Ophthalmology · doi:10.1001/archopht.120.10.1268 · Cited by 3,407
Song, S.-K., Sun, S.-W., Ju, W.-K., Lin, S.-J., Cross, A. H., & Neufeld, A. H. (2003) · NeuroImage · doi:10.1016/j.neuroimage.2003.07.005 · Cited by 1,738
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
Fisher, M., Feuerstein, G., Howells, D. W., Hurn, P. D., Kent, T. A., Savitz, S. I., & Lo, E. H. (2009) · Stroke · doi:10.1161/strokeaha.108.541128 · Cited by 1,352
A Novel Human Opsin in the Inner Retina
Provencio, I., Rodriguez, I. R., Jiang, G., Hayes, W. P., Moreira, E. F., & Rollag, M. D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00600.2000 · Cited by 1,290
Parallel processing in the mammalian retina
Wässle, H. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1497 · Cited by 1,253
Research works printed but not linked: 15
- Binley KE, 2016, Eur. J. Neurosci., 44, 2028
- Cioffi GA, 2005, Trans. Am. Ophthalmol. Soc., 103, 592
- Harwerth RS, 1999, Investig. Ophthalmol. Vis. Sci., 40, 2242
- Jia L, 2000, Investig. Ophthalmol. Vis. Sci., 41, 3415
- John SW, 1998, Investig. Ophthalmol. Vis. Sci., 39, 951
- Johnson EC, 2000, Investig. Ophthalmol. Vis. Sci., 41, 431
- Kimura A, 2017, Histol. Histopathol., 32, 215
- Levin LA, 2008, Am. J. Manag. Care, 14, S11
- Levkovitch-Verbin H, 2002, Investig. Ophthalmol. Vis. Sci., 43, 402
- May CA, 2002, Investig. Ophthalmol. Vis. Sci., 43, 2206
- Mozaffarieh M, 2008, Mol. Vis., 14, 224
- Reinstein S, 2009, Compendium, 31, 450
- Wall M, 1997, Investig. Ophthalmol. Vis. Sci., 38, 426
- WoldeMussie E, 2001, Investig. Ophthalmol. Vis. Sci., 42, 2849
- Yoles E, 1999, Investig. Ophthalmol. Vis. Sci., 40, 65
Cited by
Sorted by citations
Reprogramming to recover youthful epigenetic information and restore vision
Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., Vera, D. L., Zeng, Q., Yu, D., Bonkowski, M. S., et al. (2020) · Nature · doi:10.1038/s41586-020-2975-4 · Cited by 820
“To our knowledge, this is the first example of vision loss reversal after glaucomatous injury has occurred, with previous attempts focusing on neuroprotection delivered at an early stage to prevent further disease progression 41,42 (Supplementary discussion).”
Oxidative stress in the eye and its role in the pathophysiology of ocular diseases
Böhm, E. W., Buonfiglio, F., Voigt, A. M., Bachmann, P., Safi, T., Pfeiffer, N., & Gericke, A. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102967 · Cited by 334
Neurotoxic Reactive Astrocytes Drive Neuronal Death after Retinal Injury
Guttenplan, K. A., Stafford, B. K., El-Danaf, R. N., Adler, D. I., Münch, A. E., Weigel, M. K., Huberman, A. D., & Liddelow, S. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107776 · Cited by 221
Preservation of vision after CaMKII-mediated protection of retinal ganglion cells
Guo, X. V., Zhou, J., Starr, C. R., Mohns, E. J., Li, Y., Chen, E. P., Yoon, Y., Kellner, C. P., Tanaka, K., Wang, H., et al. (2021) · Cell · doi:10.1016/j.cell.2021.06.031 · Cited by 178
Zhang, N., Wang, J., Chen, B., Li, Y., & Jiang, B. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.624179 · Cited by 169
Margeta, M. A., Yin, Z., Madore, C., Pitts, K. M., Letcher, S. M., Tang, J., Jiang, S., Gauthier, C. D., Silveira, S. R., Schroeder, C. M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.07.014 · Cited by 130
Extraocular, periocular, and intraocular routes for sustained drug delivery for glaucoma
Kompella, U. B., Hartman, R. R., & Patil, M. A. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100901 · Cited by 129
Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells
Tian, F., Cheng, Y., Zhou, S., Wang, Q., Monavarfeshani, A., Gao, K., Jiang, W., Kawaguchi, R., Wang, Q., Tang, M., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.003 · Cited by 127
Addressing neurodegeneration in glaucoma: Mechanisms, challenges, and treatments
Ghanem, G. O. B., Wareham, L. K., & Calkins, D. J. (2024) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2024.101261 · Cited by 103
Zafar, S., Sachdeva, M. M., Frankfort, B. J., & Channa, R. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1134-5 · Cited by 83
Treatment of Glaucoma with Natural Products and Their Mechanism of Action: An Update
Sim, R. H., Sirasanagandla, S. R., Das, S., & Teoh, S. L. (2022) · Nutrients · doi:10.3390/nu14030534 · Cited by 77
Sharif, N. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.729249 · Cited by 75
Lambuk, L., Lazaldin, M. A. M., Ahmad, S., Iezhitsa, I. N., Agarwal, R., Uskoković, V., & Mohamud, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.875662 · Cited by 72
Oxidative Stress: A Suitable Therapeutic Target for Optic Nerve Diseases?
Buonfiglio, F., Böhm, E. W., Pfeiffer, N., & Gericke, A. (2023) · Antioxidants · doi:10.3390/antiox12071465 · Cited by 69
Translational Preclinical Pharmacologic Disease Models for Ophthalmic Drug Development
Shah, M., Cabrera-Ghayouri, S., Christie, L., Held, K. S., & Viswanath, V. (2019) · Pharmaceutical Research · doi:10.1007/s11095-019-2588-5 · Cited by 62
Evangelho, K. D. S., Mastronardi, C. A., & de‐la‐Torre, A. (2019) · Medicina · doi:10.3390/medicina55060280 · Cited by 57
Cammalleri, M., Monte, M. D., Amato, R., Bagnoli, P., & Rusciano, D. (2020) · Nutrients · doi:10.3390/nu12041189 · Cited by 54
RetractedAssociation of APOE With Primary Open-Angle Glaucoma Suggests a Protective Effect for APOE ε4
Margeta, M. A., Letcher, S. M., Igo, R. P., Cooke Bailey, J. N., Pasquale, L. R., Haines, J. L., Butovsky, O., Wiggs, J. L., & for the NEIGHBORHOOD consortium (2020) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.61.8.3 · Cited by 51
Rossetti, L. M., Iester, M., Tranchina, L., Ottobelli, L., Coco, G., Calcatelli, E., Ancona, C., Cirafici, P., & Manni, G. (2020) · Journal of Glaucoma · doi:10.1097/ijg.0000000000001565 · Cited by 50
Glaucoma After Corneal Trauma or Surgery—A Rapid, Inflammatory, IOP-Independent Pathway
Dohlman, C. H., Zhou, C., Lei, F., Cade, F., Regatieri, C. V., Črnej, A., Dohlman, J. G., Shen, L. Q., & Paschalis, E. I. (2019) · Cornea · doi:10.1097/ico.0000000000002106 · Cited by 49
Shen, Y., Sun, J., & Sun, X. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01838-x · Cited by 45
Basavarajappa, D. K., Galindo‐Romero, C., Gupta, V., Agudo‐Barriuso, M., Gupta, V. B., Graham, S. L., & Chitranshi, N. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101216 · Cited by 44
Microglial cGAS–STING signaling underlies glaucoma pathogenesis
Liu, Y., Wang, A., Chen, C., Zhang, Q., Shen, Q., Zhang, D., Xiao, X., Chen, S., Lian, L., Le, Z., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2409493121 · Cited by 47
Focused Update on AAV-Based Gene Therapy Clinical Trials for Inherited Retinal Degeneration
Fuller-Carter, P. I., Basiri, H., Harvey, A. R., & Carvalho, L. S. (2020) · BioDrugs · doi:10.1007/s40259-020-00453-8 · Cited by 41
Protective effect of the natural flavonoid naringenin in mouse models of retinal injury
Zeng, L., Qian, Y., Lou, H., Wang, F., Pang, Y., Hu, H., Zhang, Z., Song, Y., Liu, P., & Zhang, X. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176231 · Cited by 40
Sharif, N. A. (2018) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2017.0125 · Cited by 40
Soucy, J. R., Todd, L. J., Kriukov, E., Phay, M., Malechka, V. V., Rivera, J. D., Reh, T. A., & Baranov, P. Y. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2302089120 · Cited by 35
Circular RNA-based therapy provides sustained and robust neuroprotection for retinal ganglion cells
Jiang, W., Xiao, D., Wu, C., Yang, J., Peng, X., Chen, L., Zhang, J., Zha, G.-F., Li, W., Ju, R., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102258 · Cited by 41
Leung, C. K.-S., Ren, S. T., Chan, P. P. M., Wan, K. H.-N., Kam, A. K. W., Lai, G. W. K., Chiu, V. S. M., Ko, M. W. L., Yiu, K. F. C., & Yu, M. (2022) · Trials · doi:10.1186/s13063-021-05968-1 · Cited by 35
Yu, F., Wang, Y., Huang, C.-Q., Lin, S.-J., Gao, R.-X., & Wu, R.-Y. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369121 · Cited by 29
Zanón‐Moreno, V., Ortega‐Azorín, C., Asensio, E. M., García‐Medina, J. J., Pinazo-Duran, M. D., Coltell, Ó., Ordovás, J. M., & Corella, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112302 · Cited by 27
Treatment choices for newly diagnosed primary open angle and ocular hypertension patients
Garg, A., & Gazzard, G. (2019) · Eye · doi:10.1038/s41433-019-0633-6 · Cited by 27
Villanueva, J. R., Esteban, J. M., & Villanueva, L. R. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020094 · Cited by 26
Molecular Targets Involved in the Neuroprotection Mediated by Terpenoids
González‐Cofrade, L., Heras, B. D. L., Ticona, L. A., & Palomino, O. M. (2019) · Planta Medica · doi:10.1055/a-0953-6738 · Cited by 26
Nanoparticles for the treatment of glaucoma-associated neuroinflammation
Lambuk, L., Suhaimi, N. A. A., Sadikan, M. Z., Jafri, A. J. A., Ahmad, S., Nasir, N. A. A., Uskoković, V., Kadir, R., & Mohamud, R. (2022) · Eye and Vision · doi:10.1186/s40662-022-00298-y · Cited by 26
Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma
Yadav, K. S., Sharma, S., & Londhe, V. Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117303 · Cited by 24
Neuroprotection: A versatile approach to combat glaucoma
Naik, S., Pandey, A. P., Lewis, S. A., Rao, B. S. S., & Mutalik, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173208 · Cited by 25
Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects
Boccaccini, A., Cavaterra, D., Carnevale, C., Tanga, L., Marini, S., Bocedi, A., Lacal, P. M., Manni, G., Graziani, G., Sbardella, D., et al. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101225 · Cited by 28
Jiang, M., Ma, X., Zhao, Q., Li, Y., Xing, Y., Deng, Q., & Shen, Y. (2019) · Experimental Eye Research · doi:10.1016/j.exer.2019.107826 · Cited by 25
Geeraerts, E., Claes, M., Dekeyster, E., Salinas‐Navarro, M., Groef, L. D., den Haute, C. V., Scheyltjens, I., Baekelandt, V., Arckens, L., & Moons, L. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0872-18.2018 · Cited by 24
Tan, J., Wang, X., Cai, S., He, F., Zhang, D., Li, D., Zhu, X., Zhou, L., Fan, N., & Liu, X. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2019.11.017 · Cited by 24
The Role of MicroRNAs in Mitochondria-Mediated Eye Diseases
Carrella, S., Massa, F., & Indrieri, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.653522 · Cited by 24
Retinal Neuroprotection: Overcoming the Translational Roadblocks
Wubben, T. J., Besirli, C. G., Johnson, M. W., & Zacks, D. N. (2018) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2018.04.012 · Cited by 19
Modeling Retinal Ganglion Cell Dysfunction in Optic Neuropathies
Porciatti, V., & Chou, T.-H. (2021) · Cells · doi:10.3390/cells10061398 · Cited by 18
Glaucoma: neuroprotection with NAD-based therapeutic interventions
Chiarugi, A. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.09.010 · Cited by 19
New perspectives of immunomodulation and neuroprotection in glaucoma
Skopiński, P., Radomska-Leśniewska, D. M., Izdebska, J., Kamińska, A., Kupis, M., Kubiak, A. J., & Samelska, K. (2021) · Central European Journal of Immunology · doi:10.5114/ceji.2021.104329 · Cited by 17
Pitts, K. M., Neeson, C. E., Hall, N. E., Lin, J. B., Falah, H. K., Wang, S. L., Lo, K., Song, C., Margeta, M. A., & Valle, D. S.-D. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.11.1 · Cited by 16
Zhou, J., Chen, F., Yan, A.-M., & Xia, X. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1609996 · Cited by 16
Mutation-independent therapies for retinal diseases: focus on gene-based approaches
Carrella, S., Indrieri, A., Franco, B., & Banfi, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.588234 · Cited by 14
Association of APOE Haplotypes With Common Age-Related Ocular Diseases in 412,171 Individuals
Liuska, P. J., Rämö, J. T., Lemmelä, S. M., Kaarniranta, K., Uusitalo, H. M. T., Lahtela, E., Daly, M. J., Harju, M. P., Palotie, A. V., Turunen, J. A., et al. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.14.33 · Cited by 15
Saccà, S. C., Vernazza, S., Iorio, E. L., Tirendi, S., Bassi, A. M., Gandolfi, S., & Izzotti, A. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.06.003 · Cited by 14
A Robust Microbead Occlusion Model of Glaucoma for the Common Marmoset
Kumar, S., Benavente-Pérez, A., Ablordeppey, R. K., Lin, C. R., Viswanáthan, S., Akopian, A., & Bloomfield, S. A. (2022) · Translational Vision Science & Technology · doi:10.1167/tvst.11.1.14 · Cited by 12
Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation
Villoslada, P., Vila, G., Colafrancesco, V., Moreno, B., Fernández-Díez, B., Vázquez, R., Pertsovskaya, I., Zubizarreta, I., Pulido-Valdeolivas, I., Messeguer, J., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00717-4 · Cited by 16
Organotypic cultures as aging associated disease models
Sanchez, M. M., Bagdasarian, I. A., Darch, W., & Morgan, J. T. (2022) · Aging · doi:10.18632/aging.204361 · Cited by 12
Christopher, M. A., Hoseini, P., Walker, E., Proudfoot, J. A., Bowd, C., Fazio, M. A., Girkin, C. A., Moraes, C. G. D., Liebmann, J. M., Weinreb, R. N., et al. (2022) · Ophthalmology Glaucoma · doi:10.1016/j.ogla.2022.08.014 · Cited by 12
Porciatti, V., & Chou, T.-H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105751 · Cited by 12
Banik, S., Ghosh, A., & Debi, H. (2025) · Health Science Reports · doi:10.1002/hsr2.70542 · Cited by 10
Neuroprotection in glaucoma‑electrophysiology (Review)
Lešt�k, J., & Fůs, M. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8509 · Cited by 9
Deng, C., Yao, K., Peng, F., Zhao, B., Chen, Z., Chen, W., Zhao, Y., Zhang, H., & Wang, J. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.8.40 · Cited by 8
McLaughlin, T., Wang, J., Jia, L., Wu, F., Wang, Y., Wang, J. J., Mu, X., & Zhang, S. X. (2023) · Cells · doi:10.3390/cells12121558 · Cited by 8
Zaman, K., Nguyen, V., Prókai-Tátrai, K., & Prókai, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612592 · Cited by 8
Apelin-13 attenuates optic nerve damage in glaucomatous mice by regulating glucose metabolism
Zhang, Y., Zhao, J., Zhou, J., Jiang, Z., Cheng, K., Lei, C., & Yu, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06212-z · Cited by 8
Neuroprotective Strategies in Glaucoma - Translation to Clinical Trials
Fang, C. E. H., Guo, L., Hill, D., Yap, T. E., & Cordeiro, M. F. (2020) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2002062 · Cited by 9
Biomechanical Properties of the Sclera
Campbell, I. C., Lovald, S. T., Garcia, M. B., & Coudrillier, B. (2021) · Springer eBooks · doi:10.1007/978-3-030-64422-2_6 · Cited by 8
Cell-Based Neuroprotection of Retinal Ganglion Cells in Animal Models of Optic Neuropathies
Hu, Y., Grodzki, L. M., Bartsch, S., & Bartsch, U. (2021) · Biology · doi:10.3390/biology10111181 · Cited by 8
Jadhav, C., & Yadav, K. S. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103885 · Cited by 8
Lucchesi, M., Marracci, S., Amato, R., Lapi, D., Garrido, Á. S., Espinosa‐Martín, P., Vázquez, C. M., Mate, A., & Monte, M. D. (2024) · Nutrients · doi:10.3390/nu16030409 · Cited by 7
Kumar, S., Ramakrishnan, H., Viswanáthan, S., Akopian, A., & Bloomfield, S. A. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.9.35 · Cited by 7
Targeted Delivery of Mitochondrial Calcium Channel Regulators: The Future of Glaucoma Treatment?
Cheung, L. T. Y., Manthey, A. L., Lai, J. S. M., & Chiu, K. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00648 · Cited by 7
Sigireddi, R. R., & Frankfort, B. J. (2018) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000228 · Cited by 7
Multi-loaded PLGA microspheres as neuroretinal therapy in a chronic glaucoma animal model
Aragón-Navas, A., Rodrigo, M. J., Munuera, I., García-Herranz, D., Subías, M., Villacampa, P., García-Feijoo, J., Pablo, L. E., García‐Martín, E., Herrero‐Vanrell, R., et al. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01702-x · Cited by 6
Fluoxetine Protects Retinal Ischemic Damage in Mice
Romano, G. L., Gozzo, L., Maurel, O. M., Martino, S. D., Riolo, V., Micale, V., Drago, F., & Bucolo, C. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15051370 · Cited by 6
Reduced Plasma BDNF Levels in Normal Tension Glaucoma Compared to Open Angle Glaucoma
Sato, K., Takada, N., Fujioka, A., Himori, N., Yokoyama, Y., Tsuda, S., Omodaka, K., Kirihara, T., Ishikawa, M., Kunikata, H., et al. (2023) · Journal of Glaucoma · doi:10.1097/ijg.0000000000002257 · Cited by 7
Yi, W., Lv, D., Sun, Y., Mu, J., & Lu, X. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.149414 · Cited by 8
Soucy, J. R., Oswald, J., Kriukov, E., Phay, M., Masland, J., Pernstich, C., & Baranov, P. Y. (2025) · Translational Vision Science & Technology · doi:10.1167/tvst.14.9.27 · Cited by 4
Refractive adaptive optics scanning light ophthalmoscope with fast 2D MEMS scanner
Kunala, K., Xia, Y., Ayubi, G. A., Kowalski, B., Desai, A. X., Lippman, D. H., Bentley, J., & Dubra, A. (2025) · Biomedical Optics Express · doi:10.1364/boe.576969 · Cited by 4
Rao, P., Mishra, M., Cashman, S. M., Walton, D. S., & Kumar‐Singh, R. (2025) · Scientific Reports · doi:10.1038/s41598-025-92273-5 · Cited by 4
Bambo, M. M., & Gebremariam, M. G. (2022) · Journal of Ophthalmology · doi:10.1155/2022/9145921 · Cited by 4
Theriot, C. A., Chévez‐Barrios, P., Loughlin, T., Beheshti, A., Mercaldo, N. D., & Zanello, S. B. (2021) · Gravitational and Space Research · doi:10.2478/gsr-2021-0007 · Cited by 4
Oxidative Stress in Glaucoma: From Pathogenic Mechanisms to Emerging Antioxidant Therapies
Hanyuda, A., Tsuda, S., Takahashi, N., Sato, M., Sato, K., Himori, N., & Nakazawa, T. (2026) · Antioxidants · doi:10.3390/antiox15060751 · Cited by 3
Artificial intelligence and neural networks in the diagnosis of glaucoma
Александрович, Д. Д., Kazanova, S. Y., Movsisyan, A. B., & Poleva, R. P. (2023) · National Journal glaucoma · doi:10.53432/2078-4104-2023-22-1-115-128 · Cited by 5
Singh, K., Gupta, J. K., Jain, D., Kumar, S., Saha, S., & Sharma, A. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010304266240507050825 · Cited by 3
Decellularizing the Porcine Optic Nerve Head: Toward a Model to Study the Mechanobiology of Glaucoma
Liou, J., Drewry, M. D., Sweeney, A. M., Brown, B. N., & Geest, J. P. V. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.8.17 · Cited by 3
Etiological spectrum of irreversible blindness in Kashmir in North India
Kaushik, M., Nawaz, S., Mufti, H., & Qureshi, T. S. (2021) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_3818_20 · Cited by 3
Automated animal gimbal steering for retinal imaging and stimulation
Kunala, K., Ayubi, G. A., Franco, J. A., Mahajan, V. B., & Dubra, A. (2025) · Biomedical Optics Express · doi:10.1364/boe.582530 · Cited by 2
Elbadry, A. M. M., Aly, S. H., Abdelrazek, N. A., El‐Shiekh, R. A., Salman, A., Nabil, A., Reda, A., Eid, O., Manaa, E. G., Abdel-All, S. R., et al. (2026) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-026-00757-8 · Cited by 2
Barriers to IOP-independent treatments in glaucoma clinical trials
Gherghel, D., & Moraes, G. D. (2022) · Eye · doi:10.1038/s41433-022-02305-x · Cited by 2
Munuera, I., Aragón-Navas, A., Villacampa, P., González-Cela-Casamayor, M. A., Subías, M., Pablo, L. E., Garcia-Feijoo, J., Herrero‐Vanrell, R., García‐Martín, E., Bravo‐Osuna, I., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010009 · Cited by 2
Anti-scarring effect of sodium hyaluronate at filtration pathway after filtering surgery in rabbits
Wang, Y., Zhang, C., Zhang, W.-L., & Song, W. (2022) · International Journal of Ophthalmology · doi:10.18240/ijo.2022.04.04 · Cited by 2
DeOliveira‐Mello, L., Mack, A. F., Lara, J. M., & Arévalo, R. (2021) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2021.109096 · Cited by 2
Zhang, N., Li, Y., Zhang, X., Chrenek, M. A., Wang, J., Girardot, P. E., Sellers, J. T., Geisert, E. E., Nickerson, J. M., & Boatright, J. H. (2025) · Pharmaceuticals · doi:10.3390/ph18040569 · Cited by 1
Effect of antioxidants on primary open-angle glaucoma: a systematic review and meta-analysis
Bao, J., Yu, Y., Chen, G., Chen, H., Zhao, C., & Li, X. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1625735 · Cited by 1
Motta, I., Corsi, F., Piano, I., Bisti, S., Bergantin, E., Buzzi, M., Gargini, M. C., & Versura, P. (2026) · Biomolecules · doi:10.3390/biom16010131 · Cited by 1
Sanie‐Jahromi, F., Azimi, A., Hassanipour, H., Bostanian, P., & Khademi, B. (2024) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2024.102397 · Cited by 1
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm’s Canal
Jiang, J., Xu, J., Tao, Y., Hu, C., Zhang, C., Sun, X., Ye, C., Zhang, S., & Liang, Y. (2022) · Ophthalmic Research · doi:10.1159/000527099 · Cited by 1
Maden, M. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739135920.793582270
Liu, P. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739135920.793580966
Retina–brain axis and neuroprotection
Li, Y. M., Cheng, A. K., Manzar, H., Yap, T. E., & Cordeiro, M. F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819291-7.00023-x
Various forms of glaucoma and their treatments
Sharif, N. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-819291-7.00032-0
Metadata
- Authors
- Almasieh, M., & Levin, L. A.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- University of Wisconsin–Madison (US)
- Corresponding author
- Levin, Leonard A.
- Venue
- Annual Review of Vision Science
- Publisher
- Annual Reviews
- Published
- 2017-09-15
- Volume
- 3
- Issue
- 1
- Pages
- 91-120
- ISSN
- 2374-4642 (ISSN-L)
- 2374-4650
- OpenAlex
- W2732996930
- Cited by
- 111
- References
- 185
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 8 · 2023: 19 · 2022: 19 · 2021: 13 · 2020: 18 · 2019: 12 · 2018: 3 · 2017: 2
- FWCI
- 1.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Annual Review of Vision Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Research to Prevent Blindness
- Canada Research Chairs
- National Institutes of Health
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- glaucoma, neuroprotection, retinal ganglion cells, optic neuropathy, glaucoma animal model, neuroprotective therapy, intraocular pressure, retinal ganglion cell death, visual field defects
- MeSH terms
- Neuroprotection, Animals, Disease Models, Animal, Glaucoma, Humans, Optic Nerve Diseases, Neuroprotective Agents, Neurodegenerative Diseases, Laser Therapy, Translational Research, Biomedical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review